Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

Presentation TCT 2025

Innovation Doesn’t Follow Rules: Disruption Thrives on Freedom and Risk

Presenter: Amr Salahieh

October 25, 2025

Presentation TCT 2025

ARS 2: Structure vs. Spark: What Drives MedTech Innovation: Process or Freedom?

Presenter: Jan Garfinkle

October 25, 2025

Presentation TCT 2024

TCT 97: A Meta-Analysis of Cardioneuroablation Efficacy in Achieving Syncope Freedom in Neurocardiogenic Syncope

Presenter: Ricky E Lemus-Zamora

October 29, 2024

Presentation TCT 2023

Multidisciplinary Approach to Chronic Limb Ischemia and Limb Preservation: Our Feet are Our Freedom

Presenter: Marlen DeLong

October 23, 2023

Presentation THT 2023

Comparison between FREEDOM-HF trial patients and matched hospitalized controls from an administrative database

Presenter: Matthew Goodwin

March 21, 2023

Presentation

Individualizing Revascularization Strategy for Diabetic Patients With Multivessel CAD: FREEDOM

October 17, 2019

Presentation

SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in FREEDOM

December 10, 2018

Presentation TCT 2016

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, David J. Cohen

November 01, 2016

Presentation TCT 2015

For This Patient, I Suggest Multivessel CABG via Sternotomy, Either On-Pump or Off-Pump (FREEDOM Sets Us Free)

Presenter: John D. Puskas, Joseph F. Sabik

October 14, 2015

Presentation TCT 2015

For This Patient, I Suggest Multivessel PCI (the Freedom to Ignore FREEDOM)

Presenter: John D. Puskas, Sripal Bangalore

October 14, 2015

Presentation TCT 2015

HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Clinicians Perspective

Presenter: Bernard J. Gersh, William S. Weintraub, Ajay J. Kirtane

October 12, 2015

Presentation TCT 2015

HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Guideline Perspective

Presenter: Bernard J. Gersh, William S. Weintraub, Patrick T. O'Gara

October 12, 2015

Presentation CCVVC 2015

Have SYNTAX and FREEDOM Trial Results Changed the Interventional Practice in the USA?

Presenter: Spencer B. King

June 19, 2015

Presentation PCI Outcomes 2014

Perspectives on PCI vs CABG in the Diabetic Patient: The FREEDOM to Disagree with FREEDOM

Presenter: Gregg W. Stone

March 28, 2014

Presentation CTO 2014

EXCEL and NOBLE: Where do Left Main Trials Stand in the Shadows of SYNTAX and FREEDOM?

Presenter: Gregg W. Stone

March 01, 2014

Presentation TCT 2013

Pro Position: FREEDOM was the Final Nail in the Coffin!

Presenter: Duane Pinto

October 31, 2013

Presentation TCT 2013

FREEDOM: A Prospective, Randomized Trial of First Generation Drug-Eluting Stents vs. CABG in Insulin- and Noninsulin-Treated Diabetic Patients

Presenter: George Dangas

October 31, 2013

Presentation TCT 2013

Clinical and Angiographic Risk Stratification (from BARI 2D to FREEDOM) Influence on Treatment Outcomes

Presenter: Vasim Farooq

October 30, 2013

Presentation TCT 2013

The Great Debate: Should Diabetes Modulate the PCI vs CABG Equation? Of Course! Thank You for the FREEDOM to Speak

Presenter: David Taggart

October 29, 2013

Presentation TCT 2013

Risk Stratification in CAD: Insights From Freedom, Syntax and Beyond

Presenter: George Dangas

October 27, 2013

Advertisement

Innovation Doesn’t Follow Rules: Disruption Thrives on Freedom and Risk

ARS 2: Structure vs. Spark: What Drives MedTech Innovation: Process or Freedom?

TCT 97: A Meta-Analysis of Cardioneuroablation Efficacy in Achieving Syncope Freedom in Neurocardiogenic Syncope

Multidisciplinary Approach to Chronic Limb Ischemia and Limb Preservation: Our Feet are Our Freedom

Comparison between FREEDOM-HF trial patients and matched hospitalized controls from an administrative database

Individualizing Revascularization Strategy for Diabetic Patients With Multivessel CAD: FREEDOM

SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in FREEDOM

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

For This Patient, I Suggest Multivessel CABG via Sternotomy, Either On-Pump or Off-Pump (FREEDOM Sets Us Free)

For This Patient, I Suggest Multivessel PCI (the Freedom to Ignore FREEDOM)

HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Clinicians Perspective

HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Guideline Perspective

Have SYNTAX and FREEDOM Trial Results Changed the Interventional Practice in the USA?

Perspectives on PCI vs CABG in the Diabetic Patient: The FREEDOM to Disagree with FREEDOM

EXCEL and NOBLE: Where do Left Main Trials Stand in the Shadows of SYNTAX and FREEDOM?

Pro Position: FREEDOM was the Final Nail in the Coffin!

FREEDOM: A Prospective, Randomized Trial of First Generation Drug-Eluting Stents vs. CABG in Insulin- and Noninsulin-Treated Diabetic Patients

Clinical and Angiographic Risk Stratification (from BARI 2D to FREEDOM) Influence on Treatment Outcomes

The Great Debate: Should Diabetes Modulate the PCI vs CABG Equation? Of Course! Thank You for the FREEDOM to Speak

Risk Stratification in CAD: Insights From Freedom, Syntax and Beyond

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content